Memos Show Novartis and Wyeth Knew of PPA Link to Stroke
Tuesday, April 15th, 2003Source: The Star-Ledger Novartis Pharmaceuticals and Wyeth knew of possible health risks posed by phenylpropanolamine, or PPA in their over-the-counter medicines, despite company denials consumers could be harmed, according to memos. PPA was used in numerous cold remedies and diet pills including versions of Dimetapp and Tavist-D. In November 2000, the Food and Drug Administration [...]